Washington, DC, June 3, 2015: As key contributors to Bloomberg BNA’s recently published Health Care Program Compliance Guide, Morgan Lewis lawyers offer insights into the latest regulatory and compliance developments in a full chapter on legal and regulatory issues affecting hospice programs in the United States.
The Health Care Program Compliance Guide (available here) was developed as a resource for healthcare providers seeking reimbursement under Medicare, Medicaid, TRICARE, and other federal health care programs. Focused primarily on hospice billing requirements and practices under US government programs, Chapter 1020 Hospices was co-written by Morgan Lewis healthcare practice leader Howard Young and associates Anthony Choe and Jacob Harper. Discussing a wide range of legal and practical issues affecting hospice providers, including reimbursement, hospice caps, and care coordination with other item and service providers, the Chapter offers an in-depth assessment of key hospice issues. While covering the basics of election and certification under the Medicare program, it provides expanded analysis of underutilization of hospice care, OIG enforcement priorities, risks associated with various levels and locations of care, and hospice-specific compliance risk areas.
Recognized throughout the United States as a leader in healthcare regulatory and fraud and abuse issues, Howard Young has for more than a decade advised many hospices, both not-for-profit and for-profits, and counsels a range of other healthcare clients on government investigations, regulatory, and transactional matters, including the most critical compliance issues.
Anthony Choe advises healthcare industry clients, including hospices, on regulatory matters that involve the ever-changing US federal and state healthcare laws, including federal and state healthcare program requirements applicable to managed care organizations and providers, federal and state fraud and abuse laws.
Jacob Harper assists clients, including hospices, across the healthcare industry with a wide range of healthcare regulatory, transactional, and litigation matters focusing primarily on compliance, fraud and abuse, and reimbursement matters.